View More Recent Stories

Mar 30, 2016 09:30AM Aethlon Medical, Inc. Reports Annual Meeting Results
Mar 9, 2016 06:30AM Aethlon Medical To Present At Roth Capital Partners 28th Annual Growth Stock Conference On March 16, 2016
Feb 25, 2016 08:30AM Aethlon Medical's Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) During Life
Feb 18, 2016 09:30AM Aethlon Medical To Present At 4th Annual Sachs Cancer Bio Partnering & Investment Forum On February 24, 2016
Feb 5, 2016 09:32AM Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016
Feb 4, 2016 04:10PM Aethlon Medical Announces Fiscal 2016 Third Quarter Results
Feb 3, 2016 09:30AM Aethlon Medical Announces Dengue Virus Study Approval, Chikungunya Virus Capture Data and Completion of U.S. Principal Investigator Training
Feb 1, 2016 09:30AM Aethlon Medical to Present at the 18th Annual BIO CEO & Investor Conference
Jan 29, 2016 09:30AM Aethlon Medical To Host Third Quarter Fiscal 2016 Investor Call on February 4, 2016
Jan 12, 2016 09:00AM Aethlon Medical's Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)
Nov 16, 2015 04:01PM Aethlon Medical Announces Fiscal 2016 Second Quarter Results
Nov 10, 2015 09:30AM Aethlon Medical to Participate in the IN3 Medical Device 360 Summit
Oct 26, 2015 09:30AM Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015
Sep 28, 2015 02:45PM Aethlon Medical Extends Contract with the Defense Advanced Research Projects Agency
Sep 2, 2015 09:25AM Aethlon Medical to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
Aug 13, 2015 04:05PM Aethlon Medical Announces Fiscal 2016 First Quarter Results
Aug 6, 2015 09:00AM Aethlon Medical (AEMD) CEO Note: Nasdaq listing, equity financing and therapeutic pipeline expansion
Aug 3, 2015 09:00AM Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015
Jul 23, 2015 10:00AM Aethlon Medical, Inc. (Nasdaq: AEMD) to Ring The Nasdaq Stock Market Closing Bell
Jul 21, 2015 09:00AM Aethlon Medical to Ring the Nasdaq Stock Market Closing Bell on July 24th
Jul 13, 2015 09:40AM Aethlon Medical Begins Trading on the Nasdaq Capital Market
Jul 8, 2015 09:01AM Aethlon Medical Announces Nasdaq Capital Market Listing Approval
Jun 24, 2015 08:07AM Aethlon Medical Announces $6 Million Equity Investment
Jun 11, 2015 09:05AM Aethlon Medical Discloses Upcoming Presentations
Jun 9, 2015 08:45AM Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements
Jun 5, 2015 08:45AM Aethlon Medical to Present at the BIO International Convention
Jun 4, 2015 08:35AM Aethlon Medical Expands Clinical Research Studies to Include Chikungunya Virus
May 26, 2015 09:15AM Aethlon Medical to Present at SeeThruEquity Microcap Investor Conference
May 13, 2015 09:30AM Aethlon Medical Announces Health Canada Approval of Ebola Treatment Protocol
May 12, 2015 08:06AM Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study
May 4, 2015 08:06AM Aethlon Medical Announces Withdrawal of S-1 Registration Statement
Apr 16, 2015 12:01PM Aethlon Medical Discloses Presentation of Preliminary CTE Related Study Results
Apr 15, 2015 08:06AM Aethlon Medical Announces Cancer Clinical Trial Agreement
Apr 14, 2015 08:06AM Aethlon Medical Announces Effectiveness of Reverse Stock Split
Apr 9, 2015 08:06AM Aethlon Medical Announces Ebola Humanitarian Use Device Submission to the FDA
Apr 8, 2015 07:05AM Aethlon Medical Announces Reverse Stock Split and Nasdaq Listing Submission
Apr 2, 2015 08:05AM Aethlon Medical Discloses Head and Neck Cancer Collaboration
Mar 6, 2015 09:02AM Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference
View More Recent Stories